 

 

CLINICAL HISTORY
Not Given

OPERATIVE DIAGNOSES
Not Given

Operation/Specimen: A: Right frontal tumor, Brain, resection
8: Right frontal tumor (permanent), Brain, resection

PATHOLOGICAL DIAGNOSIS:

A and 8 Brain, right frontal, biopsy: Anapiastic oligodcndroqlioma,
MIBml:

25 30%

COMMENT
This is an oligodendroqlioma with focal areas of hypercellularity and

moderate

nuclear pleomorphism. There is increased mitotic figure in some
fragments

There is no vascular hyperplasia nor tumor necrosis. Astrocytoma
component is

no present.

 

Interpretation

POSITIVE — Methylated MGMT promoter is detected.

Results—Comments

 

 

”ﬁtted, paraffin curls labeled_ (B3) dated

TEST DESCRIPTION: Bisulfite treatment of DNA followed by PCR
amplification of

both methylated and unmethylated MGMT promoter sequences, with
products

detected by gel electrophoresis.

FDA COMMENT: The above data are not to be construed as the results
from a

stand—alone diagnostic test. This test was developed and its
performance

characteristics determined by the — laboratory as
required by CLIA '-egulations. It has not been cleared or approved
for

specific uses by the U.S. Food and Drug Administration (FDA). The FDA
has

determined that such clearance or approval is not necessary. These
results are

provided for informational purposes only, and should be interpreted
only in

the context of established procedures and/or diagnostic criteria.

 

 

INTRA—OPERATIVE CONSULTATION
Right frontal tumor, Brain, resection: Glioma, 1 block, ( KH 3

GROSS DESCRIPTION
A. multiple tissue fragments, 0.2 to 0.4 cm, all in A1, A2
B. Multiple tissue fragments, 1.5 to 2.0 cm, all in B1 to B3

ICD~9(s):

 

Histo Data
Part A: '
Taken:
Stain/ant Comment
H/E x 1 1
H/E X 1 2
H/E x 1 3
Part B: Right frontal tumor {permanent}, Brain, resection

 
 
  
 

 

 
 

Taken:
Stain/c Ordered Comment
H/E x l

H/E x l
mGFAP-DA x l
H/Exl
MIBl-DA x 1

(£0.3me

 

*** End of Report ***

 

